NOV 19, 2015 03:26 PM PST

IFN-Ɣ Beats Ebola

WRITTEN BY: Kerry Evans
The Ebola outbreak in West Africa has claimed nearly 12,000 lives since 2014, leaving researchers scrambling to develop effective vaccines and therapies.  University of Iowa researchers have a possible solution, however.  They want to treat Ebola using gamma interferon (IFN-?).

Ebola is transmitted by direct contact with infected blood and body fluids.  Symptoms of infection appear between 2 and 21 days after exposure and include fever, severe headache, vomiting, diarrhea, and hemorrhaging.  In most cases, the mortality rate is 50%.
 
Symptoms appear  2 to 21 days after infection.
Ebola infection occurs in two stages.  First, the virus infects macrophages and dendritic cells in the spleen, lymph nodes, and liver.  Second, after replicating in these cells for 3 to 4 days, the virus is shed into the bloodstream where it goes on to infect multiple other cell types.  Since IFN-? is known to activate macrophages and induce an antiviral state, the group reasoned that IFN-? treatment might inhibit Ebola during the first stage of infection.  

According to study author Wendy Maury, Ebola “goes from an early stage with a very targeted infection of only these few cell types (macrophages and dendritic cells), to everything being infected … we think what’s happening with gamma interferon is that it’s targeting macrophages and blocking the infection of those initial cell targets so you don’t get the second round of infection”.

The group infected mice with a mouse-adapted "Ebola virus" (vesicular stomatitis virus expressing Ebola surface glycoproteins), then treated them with gamma interferon.  When treated up to 24 h after infection, the mice were completely protected.  The group then investigated the mechanism by which IFN-? protected cells from the virus.  They identified 160 genes that were upregulated in macrophages by IFN-? treatment.  When a handful of these genes were upregulated experimentally, they helped ward off infection.  

The only drawback is that IFN-? treatment is probably only effective at the early stage of infection. According to Maury, “My guess is that if you delay the gamma interferon too much, you miss this window of opportunity to block the infection in macrophage cells and the gamma interferon can no longer provide protection”.

Sources: Science Daily, PLOS Pathogens, WHO, CDC, Wikipedia
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
NOV 13, 2019
Microbiology
NOV 13, 2019
Picturing a New Kind of Antibiotic
Scientists have deciphered the X-ray crystal structure of an enzyme that generates a unique broad spectrum antibiotic called obafluorin....
NOV 13, 2019
Genetics & Genomics
NOV 13, 2019
A Pathogen That Has Evolved to Spread in Hospitals
Clostridium difficile is the primary cause of infections that are acquired in hospital settings; it causes diarrhea and intestinal inflammation....
NOV 13, 2019
Microbiology
NOV 13, 2019
Electric Bacteria Form Undersea Networks of Conductivity
A team of scientists has found that bacteria can act like power lines, and send electrical currents over long distances....
NOV 13, 2019
Microbiology
NOV 13, 2019
Ticks May Spread Multiple Diseases in One Bite
The incidence of tick-borne diseases is on the rise, and ticks present a growing threat to public health worldwide....
NOV 13, 2019
Microbiology
NOV 13, 2019
Large Study Shows That Birth Mode Impacts Infant Microbiome
The microbiome is impacted by mode of birth - babies born by Cesarean section have a different microbiome than babies born vaginally....
NOV 13, 2019
Microbiology
NOV 13, 2019
Rethinking the Way Viruses Are Classified
Scientists may have to start reclassifying viruses, according to new work that shows they can take on more forms than we thought....
Loading Comments...